Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perfect Diary is the flagship brand of Yatsen Holding Limited, a leading Chinese beauty company that has strategically positioned itself at the intersection of cosmetics and biotechnology. Through its Yatsen Open Lab R&D framework, the company integrates advanced life science technologies, such as nanomedicine and bio-fermentation, into its dermatological products. Perfect Diary collaborates with prestigious institutions like the National Engineering Research Center for Nanomedicine to develop high-efficacy skincare solutions featuring targeted delivery systems. The company's portfolio expansion, including the acquisition of premium brands like Galénic and Eve Lom, underscores its commitment to science-backed clinical skincare. Listed on the NYSE as YSG, Perfect Diary represents a significant player in the evolving biotech-beauty sector, leveraging data-driven innovation and pharmaceutical-grade research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perfect Diary.